GeneDx Holdings WGS Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $102.25M-15.5% | $120.99M+3.6% | $116.74M+13.7% | $102.69M+17.9% | $87.12M-8.9% | ||
| $34.04M-7.3% | $36.72M+14.0% | $32.22M+1.3% | $31.79M+11.0% | $28.64M-2.7% | ||
| $68.21M-19.1% | $84.27M-0.3% | $84.53M+19.2% | $70.9M+21.2% | $58.48M-11.7% | ||
| 66.7%-2.9pp | 69.6%-2.8pp | 72.4%+3.4pp | 69%+1.9pp | 67.1%-2.1pp | ||
| $19.8M-19.3% | $24.54M+23.8% | $19.83M+31.5% | $15.08M+19.9% | $12.58M+8.5% | ||
| $74.59M— | —— | —— | —— | $50.45M— | ||
| $31.29M— | —— | —— | —— | $0— | ||
| -$717K-37.9% | -$520K+7.5% | -$562K+31.2% | -$817K-27.7% | -$640K+8.3% | ||
| -$4.95M-23.9% | -$4M+3.4% | -$4.14M-358% | $1.6M+205% | -$1.53M+54.9% | ||
| -$6.57M— | —— | —— | —— | $0— | ||
| -$63.32M-258% | -$17.67M-131% | -$7.64M-171% | $10.81M+266% | -$6.53M— | ||
| -61.9%-47.3pp | -14.6%-8.1pp | -6.5%-17.1pp | 10.5%+18.0pp | -7.5%— | ||
| -$2.16-254% | -$0.61-126% | -$0.27-171% | $0.38+265% | -$0.23— | ||
| 29.3M+2.4% | 28.6M-0.5% | 28.8M-3.2% | 29.8M+5.7% | 28.1M+4.7% | ||
| 29.3M+2.4% | 28.6M-0.5% | 28.8M+0.8% | 28.6M+1.5% | 28.1M+4.7% | ||
| -$717K-37.9% | -$520K+7.5% | -$562K+31.2% | -$817K-27.7% | -$640K+8.3% | ||
| $2.54M— | —— | -$3.4M-256% | $2.18M+298% | -$1.1M+44.4% | ||
| -$63.57M-258% | -$17.73M-138% | -$7.45M-169% | $10.72M+266% | -$6.45M— | ||
| $38.59M+66.4% | $23.19M+115% | $10.77M+3,012% | $346K-97.5% | $13.72M-55.8% | ||
| -$17.26M-55.8% | -$11.07M-136% | -$4.69M+87.1% | -$36.35M-286% | -$9.41M-1,713% | ||
| -$32.41M— | $0-100% | $15.77M+51.3% | $10.42M+2.3% | $10.18M+420% | ||
| -$253K— | —— | $190K+304% | -$93K-224% | $75K— | ||
| $102.25M-15.5% | $120.99M+3.6% | $116.74M+13.7% | $102.69M+17.9% | $87.12M-8.9% | ||
| -$50.66M-589% | -$7.35M-328% | $3.22M-78.7% | $15.15M+1,244% | $1.13M— | ||
| -49.5%-43.5pp | -6.1%-8.8pp | 2.8%-12.0pp | 14.8%+13.5pp | 1.3%— | ||
| -$57.47M-304% | -$14.24M-338% | -$3.25M-136% | $8.96M+297% | -$4.55M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is GeneDx Holdings's revenue?
- GeneDx Holdings (WGS) generated $442.7M in revenue over the trailing twelve months, up 34.1% year over year.
- Is GeneDx Holdings profitable?
- GeneDx Holdings is not currently profitable: it reported a net loss of $77.8M over the trailing twelve months, a -17.6% net margin.
- What are GeneDx Holdings's profit margins?
- Gross margin is 69.6% and operating margin is -14.9%, with a -17.6% net margin.
- What is GeneDx Holdings's earnings per share?
- GeneDx Holdings's diluted EPS over the trailing twelve months is $-2.68.
- Where does GeneDx Holdings's income statement data come from?
- Every line is extracted from GeneDx Holdings's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
